Company Description

DeepNephro is a biotechnology company developing human-relevant kidney organoid platforms for disease modeling, nephrotoxicity testing, and therapeutic discovery. Its technology primarily stems from peer-reviewed academic research in stem cell engineering, organoid maturation, and spatially patterned kidney assembloids.